Article

GLP in Type 2 Diabetes: Part 2

Part 2 of this program delves deeper into glucagon-like peptide-1, or GLP-1, and its therapeutic potential in type 2 diabetes. Click here to learn more.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Image credit: Gang | stock.adobe.com
Related Content
High-density lipoprotein particles(HDL) also known as good cholesterol, in the blood. Higher HDL levels correlate with lower risk of cardiovascular disease
August 22nd 2025

Elevated High-Density Lipoprotein Cholesterol May Reduce Risk of Stress Urinary Incontinence

Luke Halpern, Assistant Editor
A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025
August 22nd 2025

A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP
Hand joints inflammation. Concept of rheumatic arthritis, rheumatism, gout, joint swelling or arthralgia - Image credit: ZAY WIN HTAI | stock.adobe.com
August 22nd 2025

FDA Approves Donidalorsen as First RNA-Targeted Prophylactic Treatment for Hereditary Angioedema

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike
August 22nd 2025

Pharmacy Focus: Importance of Mental Health for Patients and Pharmacists Alike

Gustavo Alva, MD Luke Halpern, Assistant Editor
Image credit: yodiyim | stock.adobe.com
August 22nd 2025

Study: High Similarity, Efficacy Between Tocilizumab Biosimilar and Reference Product in RA

Gillian McGovern, Associate Editor
Traveling people wearing face mask in a covid pandemic in crowd, public or airport border with passport or travel restrictions. Foreigners wearing protection to prevent the spread of diseases abroad
August 22nd 2025

Non-Pharmaceutical Interventions Can Disrupt Dynamics of Pneumococcal Disease

Luke Halpern, Assistant Editor